Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2025-12-26 @ 1:22 AM
Study NCT ID:
NCT01212094
Status:
TERMINATED
Last Update Posted:
2016-03-28
First Post:
2010-09-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)
Sponsor:
National Institute of Neurological Disorders and Stroke (NINDS)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-09
Start Date Type:
None
Primary Completion Date:
2015-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12
Completion Date Type:
ACTUAL
First Submit Date:
2010-09-29
First Submit QC Date:
None
Study First Post Date:
2010-09-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-03-09
Results First Submit QC Date:
None
Results First Post Date:
2016-03-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-03-09
Last Update Post Date:
2016-03-28
Last Update Post Date Type:
ESTIMATED